KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
12.66
+0.07 (0.56%)
Aug 14, 2025, 2:32 PM - Market open
KalVista Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | 2016 - 2020 |
| Cash & Equivalents | 131.62 | 31.79 | 56.24 | 30.73 | 50.59 | Upgrade
|
| Short-Term Investments | 89 | 178.61 | 93.14 | 135.47 | 198.34 | Upgrade
|
| Cash & Short-Term Investments | 220.62 | 210.4 | 149.38 | 166.2 | 248.93 | Upgrade
|
| Cash Growth | 4.86% | 40.85% | -10.12% | -33.23% | 267.62% | Upgrade
|
| Accounts Receivable | 11 | - | - | - | - | Upgrade
|
| Other Receivables | 4.14 | 10.87 | 18.64 | 16.81 | 11.72 | Upgrade
|
| Receivables | 15.14 | 10.87 | 18.64 | 16.81 | 11.72 | Upgrade
|
| Prepaid Expenses | 5.93 | 4.42 | 4.31 | 10.64 | 3.62 | Upgrade
|
| Total Current Assets | 241.69 | 225.69 | 172.33 | 193.65 | 264.26 | Upgrade
|
| Property, Plant & Equipment | 7.53 | 9.15 | 10.77 | 10.04 | 7.55 | Upgrade
|
| Other Long-Term Assets | 1.55 | 0.57 | 0.11 | 0.19 | 0.2 | Upgrade
|
| Total Assets | 250.77 | 235.4 | 183.2 | 203.88 | 272.01 | Upgrade
|
| Accounts Payable | 4.88 | 9.11 | 4.82 | 3.64 | 1.98 | Upgrade
|
| Accrued Expenses | 27.31 | 12.4 | 9.13 | 6.96 | 6.93 | Upgrade
|
| Current Portion of Leases | 1.98 | 1.3 | 1.09 | 0.98 | 0.86 | Upgrade
|
| Current Unearned Revenue | 11 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 45.17 | 22.81 | 15.03 | 11.58 | 9.77 | Upgrade
|
| Long-Term Debt | 105.88 | - | - | - | - | Upgrade
|
| Long-Term Leases | 4.33 | 6.02 | 7.15 | 7.21 | 5.05 | Upgrade
|
| Total Liabilities | 155.38 | 28.82 | 22.18 | 18.79 | 14.82 | Upgrade
|
| Common Stock | 0.05 | 0.04 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 753.73 | 679.75 | 507.13 | 439.1 | 426.44 | Upgrade
|
| Retained Earnings | -653.17 | -469.73 | -343.08 | -250.18 | -167.84 | Upgrade
|
| Comprehensive Income & Other | -5.21 | -3.49 | -3.06 | -3.86 | -1.43 | Upgrade
|
| Total Common Equity | 95.39 | 206.58 | 161.03 | 185.09 | 257.19 | Upgrade
|
| Shareholders' Equity | 95.39 | 206.58 | 161.03 | 185.09 | 257.19 | Upgrade
|
| Total Liabilities & Equity | 250.77 | 235.4 | 183.2 | 203.88 | 272.01 | Upgrade
|
| Total Debt | 112.19 | 7.32 | 8.23 | 8.19 | 5.91 | Upgrade
|
| Net Cash (Debt) | 108.43 | 203.08 | 141.14 | 158.01 | 243.02 | Upgrade
|
| Net Cash Growth | -46.61% | 43.89% | -10.68% | -34.98% | 267.83% | Upgrade
|
| Net Cash Per Share | 2.18 | 5.52 | 5.06 | 6.46 | 12.73 | Upgrade
|
| Filing Date Shares Outstanding | 49.95 | 42.74 | 34.23 | 24.57 | 24.44 | Upgrade
|
| Total Common Shares Outstanding | 49.76 | 42.52 | 34.17 | 24.55 | 24.42 | Upgrade
|
| Working Capital | 196.52 | 202.88 | 157.29 | 182.07 | 254.49 | Upgrade
|
| Book Value Per Share | 1.92 | 4.86 | 4.71 | 7.54 | 10.53 | Upgrade
|
| Tangible Book Value | 95.39 | 206.58 | 161.03 | 185.09 | 257.19 | Upgrade
|
| Tangible Book Value Per Share | 1.92 | 4.86 | 4.71 | 7.54 | 10.53 | Upgrade
|
| Machinery | 3.64 | 3.08 | 3.05 | 2.6 | 2.01 | Upgrade
|
| Leasehold Improvements | 3.09 | 2.86 | 2.86 | 2 | 1.87 | Upgrade
|
Updated Jul 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.